Altamira Therapeutics is dedicated to developing therapeutics that address important unmet medical needs. The Company is currently active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.